BASIS WEIGHT UNIFORMITY OF LIGHTLY NEEDLED HYDROENTANGLED COTTON AND COTTON BLEND WEBS

New nonwoven products containing cotton and Lyocell (Trademarked name Tencel), low temperature thermal-bondable bicomponent olefin/polyester, or comber noils were developed using needlepunching and spunlacing (hydroentanglement). Webs containing five different blends were prepared by either light needlepunching, or light needlepunching followed by hydroentangling. We acquired detailed basis weight uniformity measurements to learn about processing and the influence of fiber blend composition on web uniformity. Basis weight uniformity was evaluated without regard to web direction ("Total" uniformity), along the machine direction (MD uniformity) and across the cross direction (CD uniformity) at numerous size resolutions. We observed that blending manufactured fibers (either Tencel or olefin/polyester) with bleached cotton and comber noils substantially improved basis weight uniformity of both types of nonwovens. We also observed that subjecting needled webs to hydroentangling significantly improved Total and MD uniformities

Análisis del mercado local de los estudios de opinión pública y mercados, y factores que inciden en su credibilidad. Estudio de caso

La industria de los estudios de opinión y de mercados atraviesa por una crisis mediática que desacredita la validez de la información generada a través de este tipo de estudios. El presente documento presenta los resultados de una investigación cualitativa que permite conocer el comportamiento de los estudios de opinión pública en sus diferentes segmentos, en particular la aplicación de los estudios de mercado; se describe el proceso y las estructuras de compra, el precio, los factores que influyen en la decisión de compra, y aborda la problemática de la identificación de los factores que inciden en la credibilidad de estos estudios

Proposed Neuroimmune Roles of Dimethyl Fumarate, Bupropion, S-Adenosylmethionine, and Vitamin D3 in Affording a Chronically Ill Patient Sustained Relief from Inflammation and Major Depression

We had discussed earlier that, after most of the primary author’s multiple sclerosis (MS) symptoms were lessened by prior neuroimmune therapies, use of dimethyl fumarate (DMF) gradually subdued his asthma and urticaria symptoms, as well as his MS-related intercostal cramping; and bupropion supplemented with S-adenosylmethionine (SAMe) and vitamin D3 (vit-D3) helped remit major depression (MD). Furthermore, the same cocktail (bupropion plus supplements), along with previously discussed routines (yoga, meditation, physical exercises, and timely use of medications for other illnesses), continued to subdue MD during new difficulties with craniopharyngioma, which caused bitemporal vision loss; sphenoid sinus infections, which caused cranial nerve-VI (CN6) palsy and diplopia; and through their treatments. Impressed with the benefit the four compounds provided, in this manuscript, we focus on explaining current neuroimmune literature proposals on how: (1) DMF impedes inflammation, oxidative stress, and cell death in CNS and peripheral tissues; (2) Bupropion curbs anxiety, MD, and enhances alertness, libido, and moods; (3) SAMe silences oxidative stress and depression by multiple mechanisms; and (4) Vit-D3 helps brain development and functioning and subdues inflammation. We realize that herein we have reviewed proposed mechanisms of remedies we discovered by literature searches and physician assisted auto-experimentation; and our methods might not work with other patients. We present our experiences so readers are heartened to reflect upon their own observations in peer-reviewed forums and make available a wide body of information for the chronically ill and their physicians to benefit from

Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions

Navzer D Sachinvala,1 Angeline Stergiou,2 Duane E Haines3,4 1Retired, US Department of Agriculture-Agricultural Research Service, New Orleans, LA 70124, USA; 2Department of Medicine, Fairfield Medical Center, Lancaster, OH 43130, USA; 3Department of Neurobiology and Anatomy, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; 4Department of Neurobiology and Anatomy, The University of Mississippi Medical Center, Jackson, MS 39216, USA Abstract: In this report, we discuss the case of an multiple sclerosis (MS) patient, age 62, who learned to attain and sustain euthymia despite his ailments. He has Ehlers Danlos Syndrome (EDS), asthma, MS, urticaria, and major depression (MD). Despite thriving limitations, the patient is an accomplished scientist, who struggled for > twelve years to emerge from being confined to bed and wheel chair with MS, to walking with crutches, scuba diving, writing manuscripts, and living a positive life. Through former educators, he reacquired problem-solving habits to study the literature on his illnesses; keep records; try new therapies; and use pharmaceutical, nutritional, physical, and psychological methods to attain euthymia. With this inculcation, years later, he discovered that dimethyl fumarate (DMF) suppressed inflammation, cramping, urticaria, and asthma; and the combination of bupropion, S-adenosylmethionine (SAMe), vitamin-D3 (vit-D3), yoga, and self-hypnosis relieved MD. Then, after a 14-month respite, the patient, discovered that he had adult onset craniopharyngioma: a benign, recurring, epithelial tumor that grows from vestigial embryonic tissue (Rathke’s pouch) which formed the anterior pituitary. The tumor grows aggressively and causes surrounding tissue and function losses. It caused headaches, disorientation, bitemporal vision loss, among other problems. To emerge from this conundrum, the patient employed his relearned habits; the above antidepressant cocktail (bupropion, SAMe, and vit-D3); and with 30 fractionated stereotactic radiation treatments shrank his tumor and gained relief. This is a single case, and methods we discovered serendipitously may not work for other chronically ill patients. Consequently, we want to encourage such patients and their physicians to discuss their experiences in peer-reviewed domains so readers may acquire new perspectives that help individualize their care, and have productive contented lives. Keywords: craniopharyngioma, euthymia, dimethyl fumarate, bupropion, S-adenosylmethionine, vitamin D

Epoxy Phosphonate Crosslinkers for Providing Flame Resistance to Cotton Textiles

Two new monomers (2-methyl-oxiranylmethyl)-phosphonic acid dimethyl ester (3) and [2-(dimethoxy-phosphorylmethyl)-oxyranylmethyl]-phosphonic acid dimethyl ester (6) were prepared and used with dicyandiamide (7) and citric acid (8) to impart flame resistance to cotton plain weave, twill, and 80:20-cotton/polyester fleece fabrics. Monomers 3 and 6 were prepared from methallyl chloride (1) and 3-chloro-2-chloromethylpropene (4) respectively via a two-step phosphorylation epoxidation sequence in 79.3 and 67.5% overall yields. H-1 and C-13 nuclear magnetic resonance (NMR) and gas chromatographic mass spectrometry (GCMS) data were used to confirm their structures. Decomposition of monomers 3 and 6 in nitrogen by thermogravimetric analysis (TGA) occurred at 110 and 220 degrees C, respectively. The mixtures of 3:7:8 and 6:7:8 (in 2:1:1 ratio) exhibited peak-curing temperatures by differential scanning calorimeter (DSC) at 125 and 150 degrees C and the temperatures were deemed suitable for curing treated fabrics without marring them. Flame-retardant treatments were applied by the pad-dry-cure methods. All untreated fabrics showed limiting oxygen index (LOI) values of about 18% oxygen in nitrogen. For formulations with monomer 3, LOI values for the three types of treated fabrics were greater than 25.5% when add-on values for the formulation were 17.4, 12.7, and 21.1%. For formulations comprising monomer 6, LOI values were greater than 28.6% when add-on values for the formulation were 18.3, 13.1, and 16.7%. With the formulation comprising monomer 3, the three fabrics passed the vertical flame test when add-on values were 21.6, 12.7, and 23.5%, respectively; and with the formulation comprising monomer 6, they passed the vertical flame test when add-on values were 13.8, 8.4, and 18.0%. In all cases char lengths of fabrics that passed the vertical flame test were less than 50% of original length and after-flame time was 0 sec and after-glow time was less than 2 sec. Published in 2007 by John Wiley & Sons, Ltd